Work

Low‐Dose Valganciclovir for Primary Cytomegalovirus Prophylaxis After Heart Transplant: A 10‐Year Experience

Year: 2025

Type: article

Study design: Observational Study

Source: Clinical Transplantation

DOI: 10.1111/ctr.70408

Authors: Kennedy Concannon, Robert Page, Rebecca Swayngim, Amrut V. Ambardekar, Chia‐Yu Chiu, Kelly Schoeppler, Emily Sartain

Institutions: University of Colorado Hospital, University of Colorado Health, University of Colorado Anschutz

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417197035

FWCI:

Cites: 29

Cited by:

Related to: